Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

Researchers are investigating whether these medications, known as GLP-1 agonists or GLP-1 drugs, could treat everything from ...

At ASCO, researchers shared that in the persevERA trial, giredestrant didn't improve outcomes for first-line advanced breast ...

You've probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss ...

Roche (RHHBF) stock is in focus as the FDA grants priority review for breast cancer therapy giredestrant with a target action ...

Foundation Medicine, Inc ., a global, patient-focused precision medicine company , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the United States (U.S.) Food and Drug Administration (FDA) has accepted the company’s New Drug Application ...

In this cohort study of patients with early breast cancer, prediagnostic statin use was not associated with higher survival; however, postdiagnostic statin use was associated with lower all-cause and ...

Welcome to the next episode of our CEO Chat series. My name is David Bautz, and I'm a Senior Biotech Analyst here at Zacks Small Cap Research . Joining me today is Dr. Steven Quay. He's the CEO of ...

Weight loss jabs are transforming obesity treatment, but without access to affordable healthy food and ongoing support they ...

Glucagon-like peptide-1 receptor agonists, aka GLP-1s, are one of the best-known synthetic peptides and the active ingredient ...

Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer ...